Reviewed by the PeptideMind Team ยท Updated August 5, 2026

Abaloparatide (Tymlos) Dosage Guide, Benefits & Side Effects

Abaloparatide (Tymlos) dosage guide: FDA-approved PTH1R agonist for osteoporosis. See daily dosing, injection instructions, benefits, side effects & bone density trial results.

As seen on

American PressStreet InsiderBusiness InsiderBenzingaCBSYahoo Finance

Abaloparatide Dosage Schedule

A once-daily injection from a prefilled pen that signals bone-building cells to work harder, helping raise density and lower fracture risk over time. Designed for consistent long-term use alongside calcium and vitamin D.

Daily Bone Density Support

105 weeks, focused on healing and recovery.

Daily dosing

Taken daily.

80 mcg per injection

80 mcg per injection, given just under the skin in the abdomen or thigh.

Abaloparatide, brand name Tymlos, is FDA-approved for osteoporosis. It comes pre-mixed in a ready-to-use prefilled pen, so no reconstitution is needed. Lifetime use is generally capped around 24 months by prescribers due to limits on long-term safety data.

August 2026
Sun
Mon
Tue
Wed
Thu
Fri
Sat
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5

What is Abaloparatide?

Abaloparatide (brand name Tymlos) is an FDA-approved medication that helps the body build new, stronger bone. It's given as a daily injection to people, mostly postmenopausal women but also some men, who are at high risk of breaking a bone due to osteoporosis. Because of how it works, it's only meant to be used for up to two years in a lifetime.

Healing

Research targets include tissue repair, wound healing, and recovery from injury.

Healing

aba

Our top-rated vendor

Our rankings are based solely on third-party lab testing rigor, COA transparency, and pricing, no paid placements, no affiliate influence. We update this list as new data comes in.

Based on current scores, this vendor ranks highest across those criteria.

Protide Health logo

Protide Health

#1 Rated Research Peptide Supplier

Visit site
View all vendors

What Does Abaloparatide Do?

It attaches to a bone-signaling receptor in a way that produces a short, sharp burst of activity rather than a constant one. That brief signal tips the balance toward cells that build new bone rather than cells that break bone down, so the net effect is bone gain.

Binds bone receptors

Attaches to the PTH1 receptor on bone-forming cells.

Short, sharp signal

Produces a brief burst of activity instead of a constant one.

Builds new bone

Tips the balance toward bone formation over breakdown.

Abaloparatide Targeted areas

Frequently Asked Questions About Abaloparatide

Straight answers on reconstitution, dosing, and safety, everything you need to research with confidence. For research reference only.

Abaloparatide Reconstitution Guide

Abaloparatide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 0.5mg, 5mg sizes.

3120 mcg lyophilized vial

Abaloparatide is supplied as a freeze-dried powder that must be mixed into a injectable solution before use. Available in 0.5mg, 5mg sizes.

NaN mL bacteriostatic water

Adding NaN mL of bac water to a 3120 mcg vial gives a workable concentration for syringe dosing. More water makes microdosing easier; less concentrates each draw.

Storage after mixing

Pre-filled pens should be refrigerated before use, then can sit at room temperature for up to a month once you start using them. As a research powder, keep it frozen long-term and refrigerate briefly once it's mixed with liquid. After reconstitution, keep the vial refrigerated and use within 30 days.

Reconstitution steps

1

Remove caps & sanitize stoppers

2

Attach needle to syringe

3

Draw NaN mL bacteriostatic water

4

Insert needle into Abaloparatide vial

5

Release water gently down the side

6

Swirl to dissolve โ€” don't shake

7

Check for full dissolution

8

Refrigerate Abaloparatide โ€” good for 30 days

Chemical Makeup

34

Amino Acids

Abaloparatide

Ala

A

Position 1

Val

V

Position 2

Ser

S

Position 3

Glu

E

Position 4

His

H

Position 5

Gln

Q

Position 6

Leu

L

Position 7

Leu

L

Position 8

His

H

Position 9

Asp

D

Position 10

Lys

K

Position 11

Gly

G

Position 12

Lys

K

Position 13

Ser

S

Position 14

Ile

I

Position 15

Gln

Q

Position 16

Asp

D

Position 17

Leu

L

Position 18

Arg

R

Position 19

Arg

R

Position 20

Arg

R

Position 21

Glu

E

Position 22

Leu

L

Position 23

Leu

L

Position 24

Glu

E

Position 25

Lys

K

Position 26

Leu

L

Position 27

Leu

L

Position 28

?

X

Position 29

Lys

K

Position 30

Leu

L

Position 31

His

H

Position 32

Thr

T

Position 33

Ala

A

Position 34

Amino acid sequence
AlaninePosition 1
ValinePosition 2
SerinePosition 3
Glutamic acidPosition 4
HistidinePosition 5
GlutaminePosition 6
LeucinePosition 7
LeucinePosition 8
HistidinePosition 9
Aspartic acidPosition 10
LysinePosition 11
GlycinePosition 12
LysinePosition 13
SerinePosition 14
IsoleucinePosition 15
GlutaminePosition 16
Aspartic acidPosition 17
LeucinePosition 18
ArgininePosition 19
ArgininePosition 20
ArgininePosition 21
Glutamic acidPosition 22
LeucinePosition 23
LeucinePosition 24
Glutamic acidPosition 25
LysinePosition 26
LeucinePosition 27
LeucinePosition 28
?Position 29
LysinePosition 30
LeucinePosition 31
HistidinePosition 32
ThreoninePosition 33
AlaninePosition 34

What Are the Benefits of Abaloparatide?

What research says it may help with, and how it works in the body.

osteoporosis fdaapproved

Approved by the FDA for postmenopausal women with osteoporosis who have a high risk of bone fractures or haven't responded to other treatments.

Approved by the FDA for men with osteoporosis who have a high fracture risk or can't tolerate other treatments.

bone health research

Large late-stage clinical trials showed it substantially reduced fractures, both in the spine and elsewhere in the body.

A clinical trial called ACTIVExtend showed that taking this drug first, then switching to another osteoporosis drug (alendronate), kept bones protected over the long term.

What Are the Side Effects of Abaloparatide?

Who should avoid it, warning signs to watch for, and what to know before combining it with other compounds.

Who Should Avoid It

Paget's disease of bone

Prior external beam or implant radiation therapy to skeleton

Bone metastases or history of skeletal malignancies

Metabolic bone diseases other than osteoporosis

Pre-existing hypercalcemia

Pregnancy or nursing

Cumulative use exceeding 2 years lifetime

Stop Right Away If You Notice

Signs of hypercalcemia (confusion, fatigue, excessive thirst)

Persistent bone pain

Severe dizziness or fainting

Allergic reactions

Milder Signs to Watch For

Cloudy or discolored solutionParticulates visibleExposed to freezing or high temperaturesDamaged pen device
Was it helpful?Yes
No

Is Abaloparatide FDA approved?

Abaloparatide is FDA approved.

FDA Approved

Abaloparatide has been reviewed and approved by the FDA for safety and efficacy in its approved indications.

Regulated Manufacturing

Manufactured under FDA-regulated quality standards, ensuring consistent purity and dosing.

Prescription Use

Legally available by prescription for its approved medical indications.

A smartphone screen displaying an app interface labeled "FDA Status," confirming a drug's approval status with a green "Yes" indicator. Below, there is an "Approved Use" section highlighting FDA approval, accompanied by usage instructions and additional information about the importance of regulatory approval for drug safety and effectiveness.

Abaloparatide Cycle Length: How Long Should It Last?

This breaks down how long a typical Abaloparatide cycle runs and what research suggests happens at each stage. Research shows that staying on a peptide continuously, without a break, may make it less effective over time.

That's why most research protocols build in a break between cycles, often called a washout period, to let the body reset before starting again.

Month 1-3
Bone formation markers increase; initial BMD changes begin
Month 3-6
Significant BMD increases at spine, hip, and femur
Month 6-12
Continued bone density improvements; fracture risk reduction
Month 12-18
Maximum benefits in ACTIVE trial; substantial fracture reduction
Month 18-24
Transition to maintenance therapy (e.g., bisphosphonates) recommended

Abaloparatide Research References

It is a fda approved compound

4Research references

Abaloparatide

Abaloparatide is a fda approved compound

ACTIVExtend Trial: Abaloparatide Followed by Alendronate

18 months abaloparatide followed by alendronate significantly reduced vertebral and nonvertebral fractures.

n.d.

Phase 2 Dose-finding Study of BA058 in Postmenopausal Women

Significant BMD increases at 40 and 80 mcg doses; abaloparatide showed superior anabolic effects on hips vs teriparatide.

n.d.

Profile of Abaloparatide and Its Potential in Postmenopausal Osteoporosis

Abaloparatide preferentially binds RG conformational state of PTH1R, producing more anabolic bone effects.

n.d.

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis (ACTIVE Trial)

Abaloparatide showed substantial reduction in vertebral fractures and greater BMD increases at spine, hip, and femur compared to placebo and teriparatide.

n.d.